Abstract
Hepatobiliary cancers are common worldwide and highly lethal. Hepatocellular carcinoma is the most common hepatobiliary malignancy and the seventh most common cancer worldwide. Gallbladder cancer is the most common biliary tract malignancy, accounting for approximately 5000 newly diagnosed cases in the United States. Cholangiocarcinomas are diagnosed throughout the biliary tree and are usually classified as intrahepatic or extrahepatic. Intrahepatic cholangiocarcinomas arise from intrahepatic small-duct radicals, whereas extrahepatic cholangiocarcinomas encompass hilar carcinomas (including Klatskin's tumors). These guidelines discuss these subtypes of hepatobiliary cancer and the epidemiology, pathology, etiology, staging, diagnosis, and treatment of each subtype.
| Original language | English |
|---|---|
| Pages (from-to) | 728-750 |
| Number of pages | 23 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 4 |
| Issue number | 8 |
| DOIs | |
| State | Published - Sep 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemoembolization
- Cholangiocarcinomas
- Cirrhosis
- Gallbladder cancer
- Hepatitis C
- Hepatocellular carcinoma
- NCCN Clinical Practice Guidelines
- Surgical resection
- Transplantation
- Tumor ablation
Fingerprint
Dive into the research topics of 'Hepatobiliary cancers clinical practice guidelines in oncology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver